Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Classical hematology 1CNS 1

Conditions

Central Nervous System Neoplasms 6Neuroblastoma 4Testicular Neoplasms 3Testicular Germ Cell Tumor 3Brain Neoplasms 3Seminoma 2Pheochromocytoma 2Ovarian Neoplasms 2Medulloblastoma 2Glioma 2Endodermal Sinus Tumor 2Thrombocytopenia 1Teratoma 1Microphthalmia, Isolated, with Coloboma 5 1Lymphoma 1Intraocular Lymphoma 1Gliosarcoma 1Glioblastoma 1Dysgerminoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Embryonal 1

Interventions

Cyclophosphamide 3liposomal amphotericin B 2Thiotepa 2Rituximab 2Psychiatric Rehabilitation 2Fentanyl 2Etoposide 2Early Intervention, Educational 2Caspofungin 2Carboplatin 2sodium thiosulfate 1sargramostim 1pegfilgrastim 1imetelstat 1etoposide phosphate 1entinostat 1carboxyamido-triazole 1Whole-Body Irradiation 1Voriconazole 1Radiotherapy 1Positron-Emission Tomography 1Pentetic Acid 1Pemetrexed 1Paclitaxel 1Oxycodone 1Nicotine 1Morphine 1Minocycline 1Methotrexate 1Methadone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intraocular Lymphoma × pegfilgrastim × CNS × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡